Highlights of the 10th International AIDS Society (IAS) Conference on HIV Science, 21-25 July 2019, Mexico City, Mexico

Affiliations

¹ European Hospital Marseille, Marseille, France.
² GU/HIV Medicine, Mortimer Market Centre, Central and North West London NHS Trust, London, UK.
³ Royal Free NHS Foundation Trust, London, UK.
⁴ Imperial College London and Imperial College NHS Trust; Imperial College NIHR Biomedical, Research Centre, London, UK.
⁵ Janssen, Pharmaceutical Companies of Johnson and Johnson. Canterbury, UK.
⁶ Department of Infectious Disease, Faculty of Medicine; Department of Genitourinary Medicine and HIV, Imperial College, London, UK.
⁷ Department of Sexual Health St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK.
⁸ Department of Infection and Immunity, Royal Free Hospital and University College, London, UK.

Editorial

Christina K Psomas et al. J Virus Erad. 2019.

. 2019 Nov 4;5(4):245-252.

doi: 10.1016/S2055-6640(20)30035-2.

¹ European Hospital Marseille, Marseille, France.
² GU/HIV Medicine, Mortimer Market Centre, Central and North West London NHS Trust, London, UK.
³ Royal Free NHS Foundation Trust, London, UK.
⁴ Imperial College London and Imperial College NHS Trust; Imperial College NIHR Biomedical, Research Centre, London, UK.
⁵ Janssen, Pharmaceutical Companies of Johnson and Johnson. Canterbury, UK.
⁶ Department of Infectious Disease, Faculty of Medicine; Department of Genitourinary Medicine and HIV, Imperial College, London, UK.
⁷ Department of Sexual Health St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK.
⁸ Department of Infection and Immunity, Royal Free Hospital and University College, London, UK.

No abstract available

References

1. Mendoza P, Gruell H, Nogueira L et al. . Combination therapy with anti-HIV-1 antibodies maintains viral suppression . Nature 2018; 561( 7724): 479– 484. - PMC - PubMed
1. Burgener A. Role of microbiome in HIV transmission and pathogenesis TUPL0102.
1. Atashili J, Poole C, Ndumbe PM et al. . Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 2008; 1493– 1501. - PMC - PubMed
1. Klatt NR, Cheu R, Birse K et al. . Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women . Science 2017; 356( 6341): 938– 945. - PubMed
1. Heffron R, McClelland RS, Balkus JE et al. . Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study. Lancet HIV 2017; 4( 10): e449– e456. - PMC - PubMed